Ruzotolimod - Roche
Alternative Names: RG-7854; RO 7020531Latest Information Update: 10 May 2024
At a glance
- Originator Roche
- Class Acetates; Alcohols; Amines; Antivirals; Ketones; Pyrimidines; Small molecules; Thiazoles
- Mechanism of Action Toll-like receptor 7 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Hepatitis B
Most Recent Events
- 09 May 2024 Roche plans to submit regulatory application for Hepatitis B in or after 2027 (Roche pipeline, May 2024)
- 10 Nov 2023 Efficacy and adverse event data from a phase II trial for Hepatitis B presented at the 74th Annual Meeting of the American Association for the Study of Liver Diseases 2023 (AASLD-2023)
- 28 Feb 2022 No recent reports of development identified for phase-I development in Hepatitis-B in Bulgaria (PO)